The Kaiser Permanente Colorado Clinical Pharmacy Anticoagulation Service as a model of modern anticoagulant care

Thrombosis Research

Volumn 123, Issue SUPPL. 1, 2008, Pages

  Witt, Daniel M ^a  

^a Clinical Pharmacy Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; ORAL CONTRACEPTIVE AGENT; VITAMIN K GROUP; WARFARIN;

ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL PHARMACY; CORONARY ARTERY DISEASE; DEEP VEIN THROMBOSIS; HEALTH CARE DELIVERY; HEALTH CARE MANAGEMENT; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; OUTPATIENT CARE; PATIENT CARE; PHARMACIST; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOEMBOLISM; THROMBOPHILIA; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; COLORADO; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; MANAGED CARE PROGRAMS; NURSING HOMES; ORTHOPEDIC PROCEDURES; OUTCOME ASSESSMENT (HEALTH CARE); PHARMACY SERVICE, HOSPITAL; PREGNANCY; QUALITY ASSURANCE, HEALTH CARE; THROMBOPHILIA; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 55549089611     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.08.004     Document Type: Article

References (15)

1. Witt D.M., and Tillman D.J. Clinical pharmacy anticoagulation services in a group model health maintenance organization. Pharm Pract Manag Q 18 (1998) 34-55
2. Wittkowski A.K., Nutescu E.A., Blackburn J., et al. Outcomes of oral anticoagulant therapy managed by telephone vs in-office visits in an anticoagulation clinic setting. CHEST 130 (2006) 1385-1389
3. Tillman D.J., Charland S., and Witt D.M. Evaluation of an outpatient deep vein thrombosis treatment program in a group model health maintenance organization. Arch Intern Med 160 (2000) 2926-2932
4. Clark N.P., Delate T., Witt D.M., Parker S., and McDuffie R. A descriptive evaluation of unfractionated heparin use during pregnancy. J Thromb Thrombolysis (March 8 2008) Electronic publication ahead of print
5. Heit J.A. Thrombophilia: common questions on laboratory assessment and management. Hematology 2007 (2007) 127-135
6. Witt D.M., Sadler M.A., Shanahan R., Mazzoli G., and Tillman D.J. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. CHEST 127 (2005) 1515-1522
7. Lousberg T.R., Witt D.M., Beall D.G., Carter B.L., and Malone D. Evaluation of excessive anticoagulation in a group model health maintenance organization. A Intern Med 158 (1998) 528-534
8. Witt D.M., and Humphries T.L. A retrospective evaluation of the management of excessive anticoagulation in an established clinical pharmacy anticoagulation service compared to traditional care. J Thromb Thrombolysis 15 (2003) 113-118
9. Anich K.V., Witt D.M., Delate T., Shanahan R., and Patel R.J. A descriptive evaluation of routine complete blood count monitoring in patients receiving anticoagulation therapy. J Thromb Thrombolysis 20 (2005) 183-188
10. Johnson S.G., Witt D.M., Delate T., and Sadler M.A. An examination of the association between therapeutic anticoagulation control and glycemic control for patients with diabetes on oral anticoagulation therapy. J Thromb Thrombolysis 19 (2005) 209-212
11. Sotaniemi E.A., Pelkonen O., Arranto A.J., Tapanainen P., Rautio A., and Pasanen M. Diabetes and elimination of antipyrine in man: an analysis of 298 patients claassified by type of diabetes, age, sex, duration of disease and liver involvement. Pharmacol Toxicol 90 (2002) 155-160
12. Chuang J., Sadler M.A., and Witt D.M. Impact of evacuated collection tube fill volume and mixing on routine coagulation testing using 2.5-ml (pediatric) tubes. CHEST 126 (2004) 1262-1266
13. Delate T., Witt D.M., Jones J.R., Bhardwaja B., and Senser M. Falsely elevated international normalized ratio values in patients undergoing anticoagulation therapy: a descriptive evaluation. CHEST 131 (2007) 816-822
14. Johnson S.G., Witt D.M., Eddy T.R., and Delate T. Warfarin and antiplatelet combination use among commercially insured patients enrolled in an anticoagulation management service. CHEST 131 (2007) 1500-1507
15. Johnson S.G., Rogers K., Delate T., and Witt D.M. Outcomes associated with combined antiplatelet and anticoagulant therapy. CHEST 133 (2008) 948-954